Cepheid Places Next-Gen PCR Systems at VA Hospitals; Cites MRSA Tests as 'Key' Business Driver
February 04, 2010
Cepheid Places Next-Gen PCR Systems at VA Hospitals; Cites MRSA Tests as 'Key' Business Driver
Cepheid also recently inked sole-source agreements with two separate entities to conduct surveillance of methicillin-resistant Staphylococcus aureus using its GeneXpert platform, company officials said last week.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - Roche, Cepheid Execs Wrangle over Clinical Market for PCR-based MRSA Tests
July 29, 2010 / PCR Insider - Cepheid Says it Shipped Six GeneXpert Infinity Systems in Q3; Most Running '24 Hours a Day'
December 10, 2009 / PCR Insider - Cepheid Reports Q4, FY '12 Revenue Growth, but Looks to Address Issues from 'Challenging' Year
January 31, 2013 / PCR Insider - Cepheid Plans 1,000-Target PCR, Protein Detection, FFPE Analysis, Other Upgrades to GeneXpert
September 27, 2012 / PCR Insider